What is Solesence, Inc.'s earnings per share (EPS)?

Solesence, Inc. (SLSN) reported diluted earnings per share of $0.02 for fiscal year 2025. This represents a -71.4% change compared to the previous fiscal year. EPS represents the portion of a company's net income allocated to each outstanding share of common stock and is widely used to evaluate profitability on a per-share basis.

Solesence, Inc. (SLSN) Financials

SLSN

Trailing 12 months to June 30, 2026

Revenue $55.4M -14.0% YoY

Net Income -$2.9M -147.9% YoY

EPS (Diluted) -$0.03 -142.9% YoY

Operating Cash Flow $1.0M +168.5% YoY

Market Cap $57.1M as of Sep 11, 2026

Price / Sales 1.0x on $55.4M revenue, trailing 12 months to June 30, 2026

Price / Earnings n/m net loss, so no earnings multiple, trailing 12 months to June 30, 2026

Price / Book 4.3x on $13.2M equity, Q2 FY2026

A multiple compares the market's price with a filed figure; it says what the market pays, not how the business is doing. The market capitalization is the vendor's as of Sep 11, 2026; every other figure is from the SEC filings on this page. Not financial advice.

Source SEC Filings (10-K/10-Q) Latest period Q2 FY2026, ended Jun 30, 2026 Reported Aug 19, 2026 Currency USD FYE December

Newest figures come from the 10-Q for Q2 FY2026, filed Aug 19, 2026. Each column of the statement tables below links to the filing it was taken from, and every filing is listed on the SLSN SEC filings page.

Solesence, Inc. (SLSN) reported $55.4M in revenue over the twelve months to Jun 30, 2026, down 14.0% from the prior twelve months. This page shows its income statement, balance sheet, cash flow statement, and key financial ratios. View 15 years of annual fundamentals and quarterly data, with year-over-year growth rates and compound annual growth rates (CAGR). All figures are derived from SEC filings (10-K and 10-Q reports).

Rhea AI SLSN FY2025 2026-09-05

Revenue expansion is being absorbed by higher operating costs, while external financing supports cash needs.

In FY2025, revenue rose to $62.1M while operating margin compressed to 2.5%, so added volume did not translate proportionally into operating profit. Operating cash flow was -$8.6M against $10.6M of financing inflow, indicating the business funded its cash needs externally during the year.

The margin shift is broader than a single below-the-line item: gross margin fell from 30.9% in FY2024 to 25.9% in FY2025. SG&A climbed to $10.4M in FY2025, helping explain why operating profit did not keep pace with revenue.

In FY2024, operating cash flow of $2.0M still became free cash flow of -$2.6M after investment spending, showing that capital intensity can consume cash even in a profitable year. The reported liquidity comparison was 1.8 months of FY2025 operating outflow, while the current ratio rose to 1.8x, separating short-term coverage from cash-generation quality.

Financial Health Signals

Financial Health Score 42/100

Scored against operating companies for FY2025. Each of the six dimensions is a percentile rank within that peer group; the overall is their average, with missing dimensions counted as zero out of six. A high score means strong standing among peers, not absolute cross-industry strength. How this score is calculated →

Health score ≠ stock price. This rates the quality of Solesence, Inc.'s business: profitability, growth, balance sheet strength. It doesn't tell you whether the stock is a good buy at today's price. Not financial advice. Use it alongside valuation analysis and your own research.

Profitability

Solesence, Inc. has an operating margin of 2.5%, meaning the company retains $3 of operating profit per $100 of revenue. This results in a moderate score of 30/100, indicating healthy but not exceptional operating efficiency. This is down from 9.8% the prior year.

Growth

Solesence, Inc.'s revenue surged 18.6% year-over-year to $62.1M, reflecting rapid business expansion. This strong growth earns a score of 89/100.

Leverage

Solesence, Inc. has elevated debt relative to equity (D/E of 2.30), meaning the company relies heavily on borrowed funds. This high leverage results in a low score of 28/100, reflecting increased financial risk.

Liquidity

Solesence, Inc.'s current ratio of 1.81 indicates adequate short-term liquidity, earning a score of 53/100. The company can meet its near-term obligations, though with limited headroom.

Cash Flow

Returns

Solesence, Inc.'s ROE of 12.7% shows moderate profitability relative to equity, earning a score of 34/100. This is down from 40.9% the prior year.

Altman Z-Score Distress

-0.28

Solesence, Inc. scores -0.28, below the 1.81 distress threshold. The score is driven primarily by a large market capitalization ($57.1M) relative to total liabilities ($32.4M). This indicates elevated financial distress risk and warrants close attention to liquidity and debt levels.

Distress-screening estimate for non-financial companies. Not computed for banks or insurers, where the Altman model does not apply.

Piotroski F-Score Partial

3/8

Solesence, Inc. passes 3 of 8 computable financial strength tests (1 of the nine could not be computed from available data). 1 of 4 profitability signals pass, 1 of 2 leverage/liquidity signals pass, 1 of 2 efficiency signals pass.

Earnings Quality No Cash Backing

$4.79used

For every $1 of reported earnings, Solesence, Inc. used $4.79 of operating cash (-$8.6M OCF vs $1.8M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely.

Interest Coverage At Risk

1.69x

Solesence, Inc. earns $1.69 in operating income for every $1 of interest expense ($1.6M vs $931K). This narrow margin raises concern about the company's ability to service its debt if operating income declines.

Key Financial Metrics

Export CSV

Earnings & Revenue

Revenue

$15.3M

YoY-24.7%

QoQ+18.3%

5Y CAGR+16.6%

10Y CAGR+15.3%

Solesence, Inc. generated $15.3M in revenue in Q2 2026. This represents a decrease of 24.7% from the same quarter a year earlier. Against the prior quarter it is up 18.3%.

EBITDA

$444K

YoY-83.6%

QoQ+214.7%

5Y CAGR-16.1%

10Y CAGR-3.7%

Solesence, Inc.'s EBITDA was $444K in Q2 2026, measuring earnings before interest, taxes, depreciation, and amortization. This represents a decrease of 83.6% from the same quarter a year earlier. Against the prior quarter it is up 214.7%.

Net Income

-$158K

YoY-104.9%

QoQ+83.6%

Solesence, Inc. reported -$158K in net income in Q2 2026. This represents a decrease of 104.9% from the same quarter a year earlier. Against the prior quarter it is up 83.6%.

EPS (Diluted)

$0.00

YoY-100.0%

QoQ+100.0%

Solesence, Inc. earned $0.00 per diluted share (EPS) in Q2 2026. This represents a decrease of 100.0% from the same quarter a year earlier. Against the prior quarter it is up 100.0%.

Cash & Balance Sheet

Cash & Debt

$1.0M

YoY-74.5%

QoQ+82.5%

5Y CAGR-0.6%

10Y CAGR-3.0%

Solesence, Inc. held $1.0M in cash as of Q2 2026; long-term debt is not reported for that period.

Shares Outstanding

71M

YoY+0.2%

QoQ0.0%

5Y CAGR+7.8%

10Y CAGR+8.5%

Solesence, Inc. had 71M shares outstanding in Q2 2026. This represents an increase of 0.2% from the same quarter a year earlier. It is unchanged from the prior quarter.

Free Cash Flow

Not reported for Q2 2026.

Dividends Per Share

Not reported for Q2 2026.

Margins & Returns

Gross Margin

31.0%

YoY-0.7pp

QoQ+6.7pp

5Y change-4.4pp

10Y change-10.1pp

Solesence, Inc.'s gross margin was 31.0% in Q2 2026, indicating the percentage of revenue retained after direct costs. This is down 0.7 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.7 percentage points.

Operating Margin

0.8%

YoY-11.4pp

QoQ+6.2pp

5Y change-12.7pp

10Y change-11.9pp

Solesence, Inc.'s operating margin was 0.8% in Q2 2026, reflecting core business profitability. This is down 11.4 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.2 percentage points.

Net Margin

-1.0%

YoY-16.9pp

QoQ+6.4pp

5Y change-1.6pp

10Y change-13.6pp

Solesence, Inc.'s net profit margin was -1.0% in Q2 2026, showing the share of revenue converted to profit. This is down 16.9 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.4 percentage points.

Return on Equity

-1.2%

YoY-23.6pp

QoQ+6.1pp

5Y change-1.8pp

10Y change-13.4pp

Solesence, Inc.'s ROE was -1.2% in Q2 2026, measuring profit generated per dollar of shareholder equity. This is down 23.6 percentage points from the same quarter a year earlier. Against the prior quarter it is up 6.1 percentage points.

Capital Allocation

R&D Spending

$947K

YoY-0.8%

QoQ-9.1%

5Y CAGR+12.1%

10Y CAGR+9.8%

Solesence, Inc. invested $947K in research and development in Q2 2026. This represents a decrease of 0.8% from the same quarter a year earlier. Against the prior quarter it is down 9.1%.

Share Buybacks

Not reported for Q2 2026.

Capital Expenditures

Not reported for Q2 2026.

SLSN Income Statement

Figures in USD, abbreviated K (thousand), M (million), B (billion), T (trillion). Negative values carry a minus sign and red type. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLSN quarterly income statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Revenue	$55.4M	$62.1M+18.6%	$52.3M+40.4%	$37.3M-0.1%	$37.3M+26.6%	$29.5M+72.1%	$17.1M+36.9%	$12.5M-11.9%	$14.2M+13.8%	$12.5M+15.7%	$10.8M+4.6%	$10.3M+3.8%	$9.9M+3.6%	$9.6M-4.5%	$10.0M+4.0%	$9.7M
Cost of Revenue	$41.2M	$46.0M+27.2%	$36.2M+22.7%	$29.5M+1.8%	$29.0M+39.3%	$20.8M+86.7%	$11.1M+12.5%	$9.9M-9.3%	$10.9M+26.5%	$8.6M+14.3%	$7.5M+4.8%	$7.2M+1.3%	$7.1M+1.1%	$7.0M-4.9%	$7.4M+1.0%	$7.3M
Gross Profit	$14.1M	$16.1M-0.8%	$16.2M+106.9%	$7.8M-6.4%	$8.4M-3.8%	$8.7M+45.1%	$6.0M+129.0%	$2.6M-20.5%	$3.3M-14.5%	$3.9M+18.8%	$3.2M+4.0%	$3.1M+10.0%	$2.8M+10.6%	$2.6M-3.1%	$2.6M+13.4%	$2.3M
R&D Expenses	$4.1M	$4.1M+6.6%	$3.8M0.0%	$3.8M+26.3%	$3.0M+35.9%	$2.2M+42.3%	$1.6M-16.0%	$1.9M-9.1%	$2.1M+18.5%	$1.7M+11.7%	$1.6M+22.1%	$1.3M-4.9%	$1.3M-20.3%	$1.7M+3.2%	$1.6M-6.3%	$1.7M
SG&A Expenses	$11.8M	$10.4M+44.1%	$7.2M-4.2%	$7.5M-0.6%	$7.6M+94.6%	$3.9M+32.8%	$2.9M-17.2%	$3.5M+8.8%	$3.3M+12.8%	$2.9M-2.3%	$3.0M-2.2%	$3.0M-6.1%	$3.2M-4.7%	$3.4M-0.9%	$3.4M-14.0%	$4.0M
Operating Income	-$1.7M	$1.6M-69.4%	$5.1M+244.7%	-$3.5M-57.0%	-$2.3M-188.2%	$2.6M+72.3%	$1.5M+153.1%	-$2.8M-38.2%	-$2.0M-162.0%	-$772K+39.1%	-$1.3M-7.6%	-$1.2M+31.6%	-$1.7M+30.9%	-$2.5M-4.3%	-$2.4M+29.0%	-$3.4M
EBITDA	N/A	$2.5M-59.3%	$6.1M+316.1%	-$2.8M-65.8%	-$1.7M-156.1%	$3.0M+63.5%	$1.8M+174.3%	-$2.5M-45.9%	-$1.7M-297.4%	-$428K+35.0%	-$658K-48.5%	-$443K+54.8%	-$980K+39.4%	-$1.6M-14.9%	-$1.4M+37.3%	-$2.2M
Interest Expense	$1.2M	$931K+39.0%	$670K-20.0%	$838K+119.4%	$382K-66.9%	$1.2M+132.7%	$496K+136.2%	$210K+262.1%	$58K+70.6%	$34K+126.7%	$15K+7.1%	$14K+133.3%	$6K-50.0%	$12K+71.4%	$7K+74.5%	$4K
Income Tax	N/A	$73K-67.8%	$227K+3683.3%	$6K+135.3%	-$17K-145.9%	$37K	N/A	N/A	$0	$0	N/A	$0	$0	$0	N/A	N/A
Net Income	-$2.9M	$1.8M-57.7%	$4.2M+196.5%	-$4.4M-67.4%	-$2.6M-213.1%	$2.3M+134.6%	$989K+132.9%	-$3.0M-44.4%	-$2.1M-163.8%	-$789K+38.5%	-$1.3M-7.6%	-$1.2M+31.0%	-$1.7M+30.3%	-$2.5M-3.6%	-$2.4M+28.9%	-$3.4M
EPS (Basic)	N/A	$0.03-57.1%	$0.07+177.8%	-$0.09-80.0%	-$0.05-200.0%	$0.05+66.7%	$0.03+137.5%	-$0.08	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
EPS (Diluted)	-$0.03	$0.02-71.4%	$0.07+177.8%	-$0.09-80.0%	-$0.05-200.0%	$0.05+66.7%	$0.03+137.5%	-$0.08	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Diluted Shares (Avg)	N/A	73M+11.6%	65M+31.2%	50M+0.9%	49M+4.4%	47M+22.0%	39M+5.3%	37M	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Revenue	$15.3M-24.7%	$13.0M-11.4%	$12.5M-0.7%	$14.6M-13.5%	$20.4M+56.1%	$14.6M+48.2%	$12.6M+56.9%	$16.9M+111.9%
Cost of Revenue	$10.6M-23.9%	$9.8M-12.7%	$9.6M-1.9%	$11.2M+4.3%	$13.9M+49.5%	$11.2M+78.8%	$9.8M+30.0%	$10.8M+67.5%
Gross Profit	$4.7M-26.3%	$3.1M-7.1%	$2.9M+3.7%	$3.4M-44.8%	$6.4M+72.3%	$3.4M-5.5%	$2.8M+487.3%	$6.1M+298.8%
R&D Expenses	$947K-0.8%	$1.0M+2.4%	$1.0M-5.3%	$1.1M+11.5%	$955K+10.5%	$1.0M+11.9%	$1.1M+39.1%	$970K-8.2%
SG&A Expenses	$3.7M+22.2%	$2.8M+32.8%	$2.2M+16.6%	$3.1M+58.7%	$3.0M+64.7%	$2.1M+35.2%	$1.9M+19.8%	$1.9M+14.1%
Operating Income	$121K-95.1%	-$700K-373.4%	-$379K-69.2%	-$781K-124.4%	$2.5M+136.5%	$256K-77.0%	-$224K+88.2%	$3.2M+361.7%
EBITDA	$444K-83.6%	-$387K-180.3%	-$158K-4050.0%	-$556K-116.2%	$2.7M+110.7%	$482K-64.2%	$4K+100.2%	$3.4M+428.4%
Interest Expense	$279K+220.7%	$263K+49.4%	$329K+204.6%	$339K+121.6%	$87K-54.5%	$176K-19.3%	$108K-51.6%	$153K-28.5%
Income Tax	N/A	N/A	N/A	N/A	$390K	N/A	N/A	N/A
Net Income	-$158K-104.9%	-$962K-380.5%	-$666K-19.1%	-$1.1M-136.8%	$3.2M+277.7%	$343K-61.6%	-$559K+73.7%	$3.0M+312.0%
EPS (Basic)	$0.00-100.0%	-$0.01	$0.01+200.0%	-$0.02-150.0%	$0.04+100.0%	$0.00-100.0%	-$0.01+75.0%	$0.04+233.3%
EPS (Diluted)	$0.00-100.0%	-$0.01	$0.00+100.0%	-$0.02-150.0%	$0.04+300.0%	$0.00-100.0%	-$0.01+75.0%	$0.04
Diluted Shares (Avg)	71M-2.7%	71M-2.8%	N/A	71M-2.0%	73M+23.6%	73M+25.2%	N/A	72M

SLSN Balance Sheet

SLSN quarterly balance sheet

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Total Assets	$46.5M-7.0%	$50.0M+52.1%	$32.9M-2.0%	$33.6M+18.2%	$28.4M+109.7%	$13.5M+44.5%	$9.4M+42.7%	$6.6M+4.8%	$6.3M+29.4%	$4.8M+5.9%	$4.6M-20.2%	$5.7M-18.5%	$7.0M-27.2%	$9.7M+6.1%	$9.1M
Current Assets	$25.2M-14.0%	$29.3M+80.0%	$16.3M-1.9%	$16.6M+43.3%	$11.6M+31.3%	$8.8M+77.2%	$5.0M+6.3%	$4.7M+1.4%	$4.6M+34.9%	$3.4M+27.4%	$2.7M-24.6%	$3.6M-21.4%	$4.5M-31.2%	$6.6M+23.3%	$5.3M
Cash & Equivalents	$1.3M-8.6%	$1.4M-18.2%	$1.7M-21.2%	$2.2M+232.7%	$657K-31.3%	$957K-19.8%	$1.2M-11.2%	$1.3M-31.2%	$2.0M+9.9%	$1.8M+39.5%	$1.3M-31.5%	$1.9M-43.2%	$3.3M-20.6%	$4.1M+53.1%	$2.7M
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0-100.0%	$30K0.0%	$30K0.0%	$30K
Inventory	$15.0M-26.2%	$20.3M+102.0%	$10.0M+13.5%	$8.8M+45.0%	$6.1M+40.4%	$4.3M+69.9%	$2.6M+13.9%	$2.2M+61.9%	$1.4M+79.4%	$772K+16.6%	$662K-30.3%	$950K-2.7%	$976K-14.3%	$1.1M-14.9%	$1.3M
Accounts Receivable	$6.8M+40.4%	$4.9M+40.4%	$3.5M-26.8%	$4.7M+20.2%	$3.9M+34.3%	$2.9M+202.3%	$970K+17.0%	$829K-25.7%	$1.1M+156.9%	$434K-14.4%	$507K+30.7%	$388K+646.2%	$52K-95.0%	$1.0M+17.3%	$879K
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$32.4M-18.2%	$39.6M+28.0%	$31.0M+11.0%	$27.9M+33.4%	$20.9M+93.6%	$10.8M+37.5%	$7.9M+51.6%	$5.2M+70.9%	$3.0M+47.9%	$2.1M+19.7%	$1.7M-9.1%	$1.9M+13.5%	$1.7M-19.1%	$2.1M+27.1%	$1.6M
Current Liabilities	$13.9M-46.0%	$25.8M+65.3%	$15.6M+12.7%	$13.8M+88.5%	$7.3M+8.2%	$6.8M+53.9%	$4.4M+21.2%	$3.6M+79.7%	$2.0M+56.1%	$1.3M+47.7%	$878K-10.0%	$976K+13.9%	$857K-28.6%	$1.2M+46.5%	$819K
Non-Current Liabilities	$18.5M+99.2%	$9.3M-39.7%	$15.4M+9.4%	$14.1M+3.6%	$13.6M+237.7%	$4.0M+16.6%	$3.5M+123.0%	$1.5M+53.3%	$1.0M+34.0%	$754K-9.7%	$835K-8.0%	$908K+13.1%	$803K-5.9%	$853K+7.2%	$796K
Long-Term Debt	N/A	N/A	N/A	$1.0M0.0%	$1.0M+5.0%	$952K	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A	N/A
Total Equity	$14.1M+36.1%	$10.4M+444.3%	$1.9M-66.3%	$5.6M-24.3%	$7.5M+173.2%	$2.7M+80.8%	$1.5M+9.2%	$1.4M-57.2%	$3.2M+15.8%	$2.8M-2.4%	$2.9M-25.6%	$3.8M-28.4%	$5.4M-29.3%	$7.6M+1.6%	$7.5M
Retained Earnings	-$102.2M-1.8%	-$100.4M+4.0%	-$104.7M-4.6%	-$100.1M-2.7%	-$97.4M+2.3%	-$99.8M+1.0%	-$100.8M-3.1%	-$97.8M-2.2%	-$95.7M-0.8%	-$94.9M-1.4%	-$93.6M-1.3%	-$92.4M-1.9%	-$90.7M-2.8%	-$88.2M-2.8%	-$85.8M

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Total Assets	$46.4M-22.5%	$44.0M-22.7%	$46.5M-7.0%	$54.0M+12.4%	$60.0M+46.8%	$57.0M+48.1%	$50.0M+52.1%	$48.0M+48.5%
Current Assets	$25.3M-34.8%	$22.7M-36.9%	$25.2M-14.0%	$32.8M+10.2%	$38.8M+59.8%	$35.9M+62.6%	$29.3M+80.0%	$29.8M+91.4%
Cash & Equivalents	$1.0M-74.5%	$573K-68.5%	$1.3M-8.6%	$429K-85.3%	$4.1M+74.2%	$1.8M-10.0%	$1.4M-18.2%	$2.9M+146.2%
Short-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Inventory	$13.0M-34.7%	$13.8M-37.0%	$15.0M-26.2%	$18.9M+25.4%	$19.8M+42.9%	$21.9M+65.0%	$20.3M+102.0%	$15.0M+48.6%
Accounts Receivable	$9.3M-15.4%	$6.4M-29.8%	$6.8M+40.4%	$9.7M+11.2%	$11.0M+86.3%	$9.1M+73.8%	$4.9M+40.4%	$8.7M+173.0%
Long-Term Investments	$0	$0	$0	$0	$0	$0	$0	$0
Total Liabilities	$33.3M-26.9%	$30.8M-33.3%	$32.4M-18.2%	$36.8M+11.8%	$45.5M+57.4%	$46.2M+37.7%	$39.6M+28.0%	$32.9M+15.7%
Current Liabilities	$26.0M+15.4%	$12.7M-61.4%	$13.9M-46.0%	$17.9M-23.3%	$22.5M+63.7%	$32.9M+170.0%	$25.8M+65.3%	$23.3M+31.9%
Non-Current Liabilities	$7.3M-62.2%	$18.1M+101.9%	$18.5M+99.2%	$18.9M+97.0%	$19.2M+26.9%	$9.0M-41.6%	$9.3M-39.7%	$9.6M-10.8%
Total Equity	$13.2M-8.8%	$13.2M+22.1%	$14.1M+36.1%	$17.2M+13.6%	$14.4M+21.0%	$10.8M+118.7%	$10.4M+444.3%	$15.2M+285.9%
Retained Earnings	-$103.3M-5.8%	-$103.1M-2.8%	-$102.2M-1.8%	-$98.8M+1.1%	-$97.7M+5.1%	-$100.3M+3.3%	-$100.4M+4.0%	-$99.9M+2.6%

Not reported in any period shown, so not listed: Goodwill, Long-Term Debt.

SLSN Cash Flow Statement

SLSN quarterly cash flow statement

Metric	TTM	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Operating Cash Flow	$1.0M	-$8.6M-534.7%	$2.0M+198.3%	-$2.0M-21.6%	-$1.6M-171.1%	$2.3M+212.6%	-$2.1M+25.8%	-$2.8M-106.9%	-$1.3M-39.8%	-$960K-298.3%	-$241K-0.4%	-$240K+79.7%	-$1.2M-126.2%	-$522K+12.9%	-$600K+79.4%	-$2.9M
Depreciation & Amortization	N/A	$897K-3.3%	$928K+25.1%	$742K+30.9%	$567K+24.9%	$454K+26.8%	$358K+13.7%	$315K-2.2%	$322K-6.4%	$344K-43.6%	$610K-17.0%	$735K-0.9%	$742K-15.2%	$875K-10.9%	$982K-12.3%	$1.1M
Stock-Based Compensation	N/A	$575K-20.7%	$725K-6.2%	$773K+23.7%	$625K+290.6%	$160K-17.9%	$195K-19.4%	$242K+18.6%	$204K+11.5%	$183K-11.6%	$207K+13.7%	$182K-3.2%	$188K-22.3%	$242K-16.8%	$291K-9.6%	$322K
Capital Expenditures	N/A	N/A	$4.6M+333.7%	$1.1M-62.8%	$2.8M+50.6%	$1.9M+113.4%	$878K+18.6%	$740K+362.5%	$160K-23.4%	$209K+63.3%	$128K-54.3%	$280K+29.6%	$216K-22.6%	$279K+83.6%	$152K+76.8%	$86K
Free Cash Flow	N/A	N/A	-$2.6M+15.4%	-$3.1M+31.7%	-$4.5M-1100.7%	$447K+115.2%	-$2.9M+16.4%	-$3.5M-134.1%	-$1.5M-28.5%	-$1.2M-216.8%	-$369K+29.0%	-$520K+62.8%	-$1.4M-74.4%	-$801K-6.6%	-$752K+75.0%	-$3.0M
Investing Cash Flow	-$1.9M	-$2.1M+53.0%	-$4.6M-333.7%	-$1.1M+62.8%	-$2.8M-50.6%	-$1.9M-113.4%	-$878K-18.6%	-$740K-362.5%	-$160K-122.2%	-$72K+56.4%	-$165K	N/A	N/A	N/A	-$167K-20.8%	-$138K
Financing Cash Flow	-$2.2M	$10.6M+365.7%	$2.3M-12.3%	$2.6M-56.8%	$6.0M+903.5%	-$747K-127.6%	$2.7M-19.7%	$3.4M+277.2%	$892K-26.2%	$1.2M+32.7%	$910K	N/A	N/A	N/A	$2.2M+65847.0%	$3K

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Operating Cash Flow	$191K+129.2%	$1.5M+121.0%	$1.8M-16.9%	-$2.5M-159.8%	-$654K-15.8%	-$7.2M-87.3%	$2.2M+182.6%	$4.2M+61.3%
Depreciation & Amortization	$323K+43.6%	$313K+38.5%	$221K-3.1%	$225K-2.6%	$225K-4.3%	$226K-3.4%	$228K+4.6%	$231K+29.8%
Stock-Based Compensation	N/A	$83K-34.6%	N/A	N/A	N/A	$127K-20.6%	N/A	N/A
Capital Expenditures	N/A	N/A	N/A	N/A	N/A	N/A	$2.6M+1203.0%	$1.4M+3322.0%
Free Cash Flow	N/A	N/A	N/A	N/A	N/A	N/A	-$404K+85.8%	$2.8M+9.2%
Investing Cash Flow	-$469K+66.7%	-$528K-497.0%	-$450K+82.6%	-$418K+70.2%	-$1.4M-195.2%	$133K+256.5%	-$2.6M-1203.0%	-$1.4M-3322.0%
Financing Cash Flow	$751K-82.7%	-$1.7M-122.7%	-$510K+54.1%	-$750K+66.4%	$4.4M+215.0%	$7.5M+77.0%	-$1.1M-132.9%	-$2.2M+37.5%

Not reported in any period shown, so not listed: Dividends Paid, Share Buybacks.

SLSN Financial Ratios

Margins and returns are percentages; the remaining ratios are unitless multiples. Each change compares the year with the year before it, and each quarter with the same quarter a year earlier.

SLSN quarterly financial ratios

Metric	FY2510-K	FY2410-K	FY2310-K	FY2210-K	FY2110-K	FY2010-K	FY1910-K	FY1810-K	FY1710-K	FY1610-K	FY1510-K	FY1410-K	FY1310-K	FY1210-K	FY1110-K
Gross Margin	25.9%-5.0pp	30.9%+9.9pp	21.0%-1.4pp	22.4%-7.1pp	29.5%-5.5pp	35.0%+14.1pp	20.9%-2.3pp	23.2%-7.7pp	30.9%+0.8pp	30.0%-0.1pp	30.2%+1.7pp	28.5%+1.8pp	26.7%+0.4pp	26.3%+2.2pp	24.1%
Operating Margin	2.5%-7.3pp	9.8%+19.3pp	-9.5%-3.5pp	-6.0%-14.7pp	8.7%0.0pp	8.7%+31.0pp	-22.4%-8.1pp	-14.2%-8.1pp	-6.2%+5.6pp	-11.8%-0.3pp	-11.4%+5.9pp	-17.3%+8.6pp	-26.0%-2.2pp	-23.8%+11.0pp	-34.8%
Net Margin	2.9%-5.2pp	8.1%+19.9pp	-11.8%-4.7pp	-7.0%-14.9pp	7.9%+2.1pp	5.8%+29.8pp	-24.0%-9.4pp	-14.7%-8.3pp	-6.3%+5.6pp	-11.9%-0.3pp	-11.6%+5.8pp	-17.4%+8.5pp	-25.8%-2.0pp	-23.8%+11.0pp	-34.8%
Return on Equity	12.7%-28.2pp	40.9%+271.7pp	-230.8%-184.4pp	-46.4%-77.5pp	31.1%-5.1pp	36.2%+235.1pp	-198.9%-48.6pp	-150.4%-126.0pp	-24.4%+21.6pp	-46.0%-4.3pp	-41.7%+3.2pp	-44.9%+1.3pp	-46.2%-14.7pp	-31.5%+13.5pp	-45.0%
Return on Assets	3.9%-4.6pp	8.5%+21.8pp	-13.4%-5.5pp	-7.8%-16.0pp	8.2%+0.9pp	7.3%+39.4pp	-32.1%-0.4pp	-31.7%-19.1pp	-12.6%+13.9pp	-26.5%-0.4pp	-26.1%+4.1pp	-30.1%+5.1pp	-35.3%-10.5pp	-24.8%+12.2pp	-37.0%
Current Ratio	1.81+0.7x	1.14+0.1x	1.05-0.2x	1.20-0.4x	1.58+0.3x	1.30+0.2x	1.13-0.2x	1.29-1.0x	2.28-0.4x	2.64-0.4x	3.06-0.6x	3.65-1.6x	5.29-0.2x	5.49-1.0x	6.53
Debt-to-Equity	2.30-1.5x	3.83-12.5x	16.29+16.1x	0.180.0x	0.13-0.2x	0.35-4.9x	5.20+1.5x	3.75+2.8x	0.94+0.2x	0.73+0.1x	0.60+0.1x	0.49+0.2x	0.310.0x	0.27+0.1x	0.22
Asset Turnover	1.33+0.3x	1.05-0.1x	1.130.0x	1.11+0.1x	1.04-0.2x	1.26-0.1x	1.33-0.8x	2.16+0.2x	1.99-0.2x	2.230.0x	2.25+0.5x	1.73+0.4x	1.36+0.3x	1.040.0x	1.06
FCF Margin	N/A	-4.9%+3.3pp	-8.2%+3.8pp	-12.0%-13.5pp	1.5%+18.7pp	-17.2%+11.0pp	-28.1%-17.5pp	-10.6%-1.2pp	-9.4%-6.0pp	-3.4%+1.6pp	-5.0%+9.0pp	-14.1%-5.7pp	-8.3%-0.9pp	-7.5%+23.6pp	-31.1%

Metric	Q2'2610-Q	Q1'2610-Q	Q4'2510-Q	Q3'2510-Q	Q2'2510-Q	Q1'2510-Q	Q4'2410-K	Q3'2410-Q
Gross Margin	31.0%-0.7pp	24.2%+1.1pp	23.0%+1.0pp	23.1%-13.1pp	31.6%+3.0pp	23.1%-13.2pp	22.0%+16.1pp	36.2%+17.0pp
Operating Margin	0.8%-11.4pp	-5.4%-7.2pp	-3.0%-1.3pp	-5.3%-24.3pp	12.2%+4.1pp	1.8%-9.5pp	-1.8%+21.9pp	19.0%+34.3pp
Net Margin	-1.0%-16.9pp	-7.4%-9.8pp	-5.3%-0.9pp	-7.7%-25.7pp	15.9%+9.3pp	2.4%-6.7pp	-4.5%+22.1pp	18.1%+36.1pp
Return on Equity	-1.2%-23.6pp	-7.3%-10.5pp	-4.7%+0.7pp	-6.5%-26.6pp	22.4%+15.2pp	3.2%-14.9pp	-5.4%+106.5pp	20.1%+56.6pp
Return on Assets	-0.3%-5.7pp	-2.2%-2.8pp	-1.4%-0.3pp	-2.1%-8.4pp	5.4%+3.3pp	0.6%-1.7pp	-1.1%+5.3pp	6.3%+10.8pp
Current Ratio	0.97-0.7x	1.79+0.7x	1.81+0.7x	1.84+0.6x	1.720.0x	1.09-0.7x	1.14+0.1x	1.28+0.4x
Debt-to-Equity	2.53-0.6x	2.33-1.9x	2.30-1.5x	2.130.0x	3.16+0.7x	4.27-2.5x	3.83-12.5x	2.17+1.9x
Asset Turnover	0.330.0x	0.290.0x	0.270.0x	0.27-0.1x	0.340.0x	0.260.0x	0.250.0x	0.35+0.1x
FCF Margin	N/A	N/A	N/A	N/A	N/A	N/A	-3.2%+32.4pp	16.6%-15.6pp

Similar Companies

Newest fiscal year on record for each company. The health score is the peer-relative Financial Health Score for that year; a dash means no score is published for it.

Company	Fiscal year	Revenue	Net income	Net margin	Market cap	Health score
Solesence, Inc. SLSN	FY2025	$62.1M	$1.8M	2.9%	$57.1M	42/100
Waldencast plc WALD	FY2025	$272.1M	-$229.7M	-84.4%	$170.6M	40/100
European Wax Center, Inc. EWCZ	FY2026	N/A	$8.7M	N/A	$257.9M	—
Acme United Corp ACU	FY2025	$196.5M	$10.2M	5.2%	$235.2M	59/100
Big Tree Cloud Holdings Limited DSY	FY2025	$2.6M	-$32.5M	N/A	$18.1M	8/100
Skinhealth Systems Inc SKIN	FY2025	$300.8M	-$9.5M	-3.2%	$89.8M	29/100

Where Solesence, Inc. Ranks

Frequently Asked Questions

What is Solesence, Inc.'s annual revenue?

Solesence, Inc. (SLSN) reported $62.1M in total revenue for fiscal year 2025. This represents a 18.6% change compared to the previous fiscal year. Revenue measures the total income earned from the company's primary business operations before any expenses are deducted.

How fast is Solesence, Inc.'s revenue growing?

Solesence, Inc. (SLSN) revenue grew by 18.6% year-over-year, from $52.3M to $62.1M in fiscal year 2025.

Is Solesence, Inc. profitable?

Yes, Solesence, Inc. (SLSN) reported a net income of $1.8M in fiscal year 2025, with a net profit margin of 2.9%.

What is Solesence, Inc.'s EBITDA?

Solesence, Inc. (SLSN) had EBITDA of $2.5M in fiscal year 2025, measuring earnings before interest, taxes, depreciation, and amortization.

What is Solesence, Inc.'s gross margin?

Solesence, Inc. (SLSN) had a gross margin of 25.9% in fiscal year 2025, indicating the percentage of revenue retained after direct costs of goods sold.

What is Solesence, Inc.'s operating margin?

Solesence, Inc. (SLSN) had an operating margin of 2.5% in fiscal year 2025, reflecting the profitability of core business operations before interest and taxes.

What is Solesence, Inc.'s net profit margin?

Solesence, Inc. (SLSN) had a net profit margin of 2.9% in fiscal year 2025, representing the share of revenue converted into profit after all expenses.

What is Solesence, Inc.'s return on equity (ROE)?

Solesence, Inc. (SLSN) has a return on equity of 12.7% for fiscal year 2025, measuring how efficiently the company generates profit from shareholder equity.

What is Solesence, Inc.'s operating cash flow?

Solesence, Inc. (SLSN) recorded an outflow of $8.6M in operating cash flow during fiscal year 2025, representing cash used by core business activities.

What are Solesence, Inc.'s total assets?

Solesence, Inc. (SLSN) had $46.5M in total assets as of fiscal year 2025, including both current and long-term assets.

How much does Solesence, Inc. spend on research and development?

Solesence, Inc. (SLSN) invested $4.1M in research and development during fiscal year 2025.

How many shares does Solesence, Inc. have outstanding?

Solesence, Inc. (SLSN) had 71M shares outstanding as of fiscal year 2025.

What is Solesence, Inc.'s current ratio?

Solesence, Inc. (SLSN) had a current ratio of 1.81 as of fiscal year 2025, which is generally considered healthy.

What is Solesence, Inc.'s debt-to-equity ratio?

Solesence, Inc. (SLSN) had a debt-to-equity ratio of 2.30 as of fiscal year 2025, measuring the company's financial leverage by comparing total debt to shareholder equity.

What is Solesence, Inc.'s return on assets (ROA)?

Solesence, Inc. (SLSN) had a return on assets of 3.9% for fiscal year 2025, measuring how efficiently the company uses its assets to generate profit.

What is Solesence, Inc.'s P/E ratio?

Solesence, Inc. (SLSN) has no price-to-earnings ratio at the moment: net loss, so no earnings multiple (trailing 12 months to June 30, 2026). The market capitalization is $57.1M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

What is Solesence, Inc.'s price-to-sales ratio?

Solesence, Inc. (SLSN) trades at 1.0x sales, its market capitalization divided by revenue of $55.4M revenue, trailing 12 months to June 30, 2026. The market capitalization is $57.1M as of Sep 11, 2026; a multiple compares that price with a filed figure and says nothing about the quality of the business.

How does Solesence, Inc.'s liquidity compare with its operating cash outflow?

At the end of fiscal year 2025, Solesence, Inc. (SLSN) held $1.3M in cash, cash equivalents and investments, and reported an operating cash outflow of $8.6M over that year. Dividing the one by the other, the reported balance equals about 2 months of the outflow reported that year. This is arithmetic over figures already filed, not a projection: it assumes nothing about future spending, financing or operations.

What is Solesence, Inc.'s Altman Z-Score?

Solesence, Inc. (SLSN) has an Altman Z-Score of -0.28, placing it in the Distress Zone (elevated bankruptcy risk). The Z-Score combines five financial ratios (working capital, retained earnings, EBIT, market capitalization, and revenue relative to total assets) to predict the likelihood of bankruptcy. Scores above 2.99 indicate financial safety while scores below 1.81 suggest financial distress. Learn more in our complete guide to financial health indicators.

What is Solesence, Inc.'s Piotroski F-Score?

Solesence, Inc. (SLSN) has a Piotroski F-Score of 3 out of 8 computable signals; 1 of the nine could not be computed from available data, so the full-scale strength rating is not shown. The F-Score evaluates nine binary signals across profitability (positive ROA, positive cash flow, improving ROA, earnings quality), leverage (decreasing debt, improving liquidity, no share dilution), and operating efficiency (improving gross margin, improving asset turnover). Scores of 7 to 9 indicate strong and improving fundamentals. Learn more in our complete guide to financial health indicators.

Are Solesence, Inc.'s earnings high quality?

For every $1 of reported earnings, Solesence, Inc. (SLSN) used $4.79 of operating cash (-$8.6M OCF vs $1.8M net income). Earnings that no cash stands behind rest on accounting accruals, which cannot be repeated indefinitely. This ratio compares operating cash flow to net income. A ratio above 1.0x means the company generates more cash than its reported earnings, indicating sustainable, cash-backed profits. Ratios below 1.0x suggest earnings rely on accounting accruals rather than actual cash generation. Learn more in our complete guide to financial health indicators.

Can Solesence, Inc. cover its interest payments?

Solesence, Inc. (SLSN) has an interest coverage ratio of 1.69x, meaning it can struggle to cover its interest obligations. This ratio divides operating income by interest expense. Ratios above 5x indicate strong debt-servicing ability, while ratios below 2x suggest the company may face difficulty meeting interest payments if earnings decline. Learn more in our complete guide to financial health indicators.

How financially healthy is Solesence, Inc.?

Solesence, Inc. (SLSN) scores 42 out of 100 on our Financial Health Score, indicating moderate standing within its operating companies peer group. The score is a 0-100 composite of six dimensions (Profitability, Growth, Leverage, Liquidity, Cash Flow, Returns), each ranked as a percentile relative to companies in the same scoring family (banks against banks, REITs against REITs, and so on) rather than across all industries. It rates the quality of the business, not whether the stock is fairly priced, and is not financial advice. Learn more in our complete guide to financial health indicators.